Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Jakarta - Delayed Quote IDR

PT Klinko Karya Imaji Tbk (KLIN.JK)

Compare
156.00
0.00
(0.00%)
At close: April 11 at 4:00:02 PM GMT+7
Loading Chart for KLIN.JK
  • Previous Close 156.00
  • Open 156.00
  • Bid 155.00 x --
  • Ask 157.00 x --
  • Day's Range 154.00 - 156.00
  • 52 Week Range 10.00 - 232.00
  • Volume 594,500
  • Avg. Volume 8,406,552
  • Market Cap (intraday) 203.975B
  • Beta (5Y Monthly) -0.57
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Klinko Karya Imaji Tbk produces and sells cleaning products containing recycled textile waste materials in Indonesia and internationally. The company provides mats, duster, mops, and napkins. It serves manufactures in pharmaceutical, medical devices, microelectronics, automotive, and other sectors. PT Klinko Karya Imaji Tbk was founded in 2016 and is based in Gresik, Indonesia. As of February 13, 2025, PT Klinko Karya Imaji Tbk operates as a subsidiary of PT Samico Capital Utama Mulia.

klinko.id

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KLIN.JK

View More

Performance Overview: KLIN.JK

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

KLIN.JK
17.46%
IDX COMPOSITE (^JKSE)
11.55%

1-Year Return

KLIN.JK
940.00%
IDX COMPOSITE (^JKSE)
14.06%

3-Year Return

KLIN.JK
73.33%
IDX COMPOSITE (^JKSE)
13.07%

5-Year Return

KLIN.JK
73.33%
IDX COMPOSITE (^JKSE)
34.70%

Compare To: KLIN.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KLIN.JK

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    203.97B

  • Enterprise Value

    203.97B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.60%

  • Return on Assets (ttm)

    5.95%

  • Return on Equity (ttm)

    6.39%

  • Revenue (ttm)

    22.09B

  • Net Income Avi to Common (ttm)

    2.12B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    133.04M

  • Total Debt/Equity (mrq)

    25.28%

  • Levered Free Cash Flow (ttm)

    -1.74B

Research Analysis: KLIN.JK

View More

Company Insights: KLIN.JK

Research Reports: KLIN.JK

View More

People Also Watch